Literature DB >> 32272221

Host proteases as determinants of coronaviral neurotropism and virulence.

George D Vavougios1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32272221      PMCID: PMC7135707          DOI: 10.1016/j.bbi.2020.04.010

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


× No keyword cloud information.
To the Editor: Recently, the study by Wu et al. (2020) presented a concise report on the epidemiological and molecular underpinnings of coronaviral neurotropism, and their potential implications for COVID-19 disease phenotypes. The report presented by the authors covers an important aspect of coronaviral infections, that may be increasingly recognized as COVID-19′s clinical phenotypes expand. An equally important parameter of coronaviral nervous system involvement that was not covered in this paper, despite being directly implied by its aim, was the interaction between host and virus at protease cleavage sites, as a determinant of neurotropism and virulence. Spike protein cleavage at specific residues by host proteases is considered a priming step during SARS coronaviral infection, subsequently determining adsorption, tissue tropism and host compatibility (Millet and Whittaker, 2015). Despite the genomic similarities with other betacoronaviruses, including SARS-CoV, SARS-CoV-2 was recently shown to contain a unique furin-like cleavage site in its spike protein (Coutard et al., 2020). Interactions between host furin-like proteases and furin-like cleavage sites have been previously shown to be important determinants of neurotropism in other coronaviridae, with cleavage status determining disease phenotype (Cheng et al., 2019;11(10).). Interestingly, in a murine model examining the neurotropic potential of the human coronavirus strain O43 (HCoV-O43), a furin-protease gain-of-function mutation did not impact neuroinvasion, but did affect viral egress, producing a more indolent and correspondingly persistent pathogen within the CNS (Le coupanec et al., 2015).

Declarations

Ethics approval and consent to participate: Not applicable. Consent for publication: Not applicable/Single Author. Availability of data and materials: Not applicable. Competing interests: None declared. Funding: No funding source. Authors' contributions: Single Author. Acknowledgements: To Dr Maria Chatzi MD, for her guidance and updates on the literature.
  1 in total

Review 1.  Host cell proteases: Critical determinants of coronavirus tropism and pathogenesis.

Authors:  Jean Kaoru Millet; Gary R Whittaker
Journal:  Virus Res       Date:  2014-11-22       Impact factor: 3.303

  1 in total
  6 in total

1.  SARS-CoV-2 dysregulation of PTBP1 and YWHAE/Z gene expression: A primer of neurodegeneration.

Authors:  George D Vavougios
Journal:  Med Hypotheses       Date:  2020-08-26       Impact factor: 1.538

2.  Clinical features of SARS-CoV-2-associated encephalitis and meningitis amid COVID-19 pandemic.

Authors:  Liang Huo; Kai-Li Xu; Hua Wang
Journal:  World J Clin Cases       Date:  2021-02-16       Impact factor: 1.337

Review 3.  The three frontlines against COVID-19: Brain, Behavior, and Immunity.

Authors:  Shao-Cheng Wang; Kuan-Pin Su; Carmine M Pariante
Journal:  Brain Behav Immun       Date:  2021-02-04       Impact factor: 7.217

Review 4.  The relevant information about the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) using the five-question approach (when, where, what, why, and how) and its impact on the environment.

Authors:  Faizah A AlMalki; Salim Albukhaty; Amal A Alyamani; Moayad N Khalaf; Sabu Thomas
Journal:  Environ Sci Pollut Res Int       Date:  2022-02-17       Impact factor: 5.190

Review 5.  Impact of SARS-CoV-2 on neuropsychiatric disorders.

Authors:  Maria Angeles Robinson-Agramonte; Carlos-Alberto Gonçalves; Elena Noris-García; Naybí Préndes Rivero; Anna Lisa Brigida; Stephen Schultz; Dario Siniscalco; Ramiro Jorge García García
Journal:  World J Psychiatry       Date:  2021-07-19

Review 6.  Severe acute respiratory syndrome coronavirus 2 infection reaches the human nervous system: How?

Authors:  Vladimir N Uversky; Fatma Elrashdy; Abdullah Aljadawi; Syed Moasfar Ali; Rizwan Hasan Khan; Elrashdy M Redwan
Journal:  J Neurosci Res       Date:  2020-11-20       Impact factor: 4.433

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.